Vac­ci­na­tion boost

Seymour Telegraph - - NEWS -

Can­cer Coun­cil Vic­to­ria has wel­comed the Phar­ma­ceu­ti­cal Ben­e­fits Ad­vi­sory Com­mit­tee’s (PBAC) rec­om­men­da­tion to in­clude Gar­dasil 9 in the Na­tional Im­mu­ni­sa­tion Pro­gram.

The new, more ef­fec­tive HPV vac­ci­na­tion will boost pro­tec­tion against cer­vi­cal can­cer in fully vac­ci­nated fe­males to 90 per cent in just two vac­ci­na­tion doses.

This com­pares to the cur­rent vac­ci­na­tion, which of­fers women 77 per cent pro­tec­tion.

Can­cer Coun­cil Vic­to­ria screen­ing, early de­tec­tion and im­mu­ni­sa­tion man­ager Kate Broun said the new vac­ci­na­tion would pro­vide women with greater pro­tec­tion against cer­vi­cal can­cer.

‘‘We know there are 13 types of HPV as­so­ci­ated with de­vel­op­ing cer­vi­cal can­cer,’’ she said.

‘‘The new vac­cine in­cludes nine of these types, lift­ing pro­tec­tion from 77 to 90 per cent.’’

Gar­dasil 9 will pro­vide fully vac­ci­nated women with pro­tec­tion against all the HPV strains in the cur­rent quadri­va­lent vac­cine, as well as the five next most com­mon HPV types found in cer­vi­cal can­cer (types 31, 33, 45, 52 and 58).

It of­fers bet­ter pro­tec­tion from two, in­stead of three, doses of the vac­ci­na­tion.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.